Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaLorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 153
- Run by
- Guangdong Association of Clinical Trials
See details and how to joinNCT07750704 - 1. fázisTaking peopleA Phase Ib Study of GC101 in NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Shanghai Juncell Therapeutics
See details and how to joinNCT06473961 - 2. fázisTaking peopleA Phase II Study of GC101 in NSCLC
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 28
- Run by
- Shanghai Juncell Therapeutics
See details and how to joinNCT07560111 - No phaseTaking peopleEffect of Modified Arm Positioning on Shoulder Pain After Thoracoscopic Lobectomy
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 270
- Run by
- Chengdu Jinjiang Maternity and Child Health Hospital
See details and how to joinNCT07746323 - 2. fázisTaking peopleAdjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
- Where
- Chengdu, Suining
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Sichuan University
See details and how to joinNCT07748325 - 1/2. fázisTaking peopleAdaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Beijing Biotech
See details and how to joinNCT07744256 - 1/2. fázisTaking peopleAmivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 15
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07744529 - 4. fázisTaking peopleMetronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
- Where
- Hefei
- Életkor
- 18 év to 75 év
- People
- 107
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT07744698 - 2. fázisNot yet taking people in KínaSafety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT07745790 - No phaseTaking peopleShort-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung Cancer Patients
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06215326 - 2/3. fázisTaking peopleA Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07642024 - 2. fázisTaking peopleTargeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 160
- Run by
- Peng Zhang
See details and how to joinNCT07742332 - No phaseNot yet taking people in KínaMulti-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 160
- Run by
- HAN GUANG
See details and how to joinNCT07742800 - 2. fázisCsak meghívásosBronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC
- Where
- Fuzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07738367 - 1. fázisTaking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Beijing, Chongqing, Jinan
- Életkor
- 18 év and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - 2. fázisTaking peopleA Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07308106 - 1/2. fázisTaking peopleA Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 265
- Run by
- Akeso
See details and how to joinNCT07623356 - 3. fázisTaking peoplePhase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Where
- Anyang, Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangdong, Guangzhou, Hangzhou, Harbin, Hefei, Henan, Jinan, Jining, Nanchang, Qingdao, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xiamen, Yinchuan
- Életkor
- 18 év and over
- People
- 756 worldwide
- Run by
- Shanghai Junshi Bioscience Co., Ltd.
See details and how to joinNCT06095583 - 2. fázisTaking peopleIBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
- Where
- Shenyang
- Életkor
- 18 év to 75 év
- People
- 170
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07122687 - No phaseCsak meghívásosComparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
- Where
- Beijing
- People
- 354
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07373899 - 1. fázisTaking peopleAPG-2449 in Patients With Advanced Solid Tumors
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 165
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT03917043 - 2. fázisTaking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Chengdu, Hangzhou, Jinan, Nanchang, Shanghai
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - 2. fázisTaking peopleA Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 66
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06437509 - 2. fázisTaking peopleA Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 570
- Run by
- Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT06475300 - 1. fázisTaking peopleStudy of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 493
- Run by
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07589205